Gammopathy with IgA mesangial deposition provides a monoclonal model of IgA nephritogenicity and offers new insights into its molecular mechanisms

Nephrology Dialysis Transplantation

Volumn 26, Issue 12, 2011, Pages 3930-3937

  Boumediene, Ahmed ^a,b   Oblet, Christelle ^a,b   Oruc, Zeliha ^a,b   Duchez, Sophie ^a,b   Morelle, Willy ^c   Huynh, Anne ^d   Pourrat, Jacques ^d   Aldigier, Jean Claude ^a,b   Cogné, Michel ^a,b  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

^b CNRS   (France)

^c UNIVERSITÉ DES SCIENCES ET TECHNOLOGIES DE LILLE   (France)

^d CHU PURPAN   (France)

Author keywords

Henoch Sch nlein purpura; IgA monoclonal gammopathy; IgA ANCA; necrotizing vasculitis

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A1; LACTOFERRIN; PREDNISOLONE; PREDNISONE;

AGED; AMINO ACID SEQUENCE; ANAPHYLACTOID PURPURA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; C1GALT1 GENE; CASE REPORT; CELL CLONE; CONTROLLED STUDY; FEMALE; FOCAL GLOMERULOSCLEROSIS; GENE; GENE EXPRESSION; GLYCOSYLATION; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY FAILURE; LEUKOCYTOCLASTIC VASCULITIS; LOW DRUG DOSE; MOLECULAR MECHANICS; MONOCLONAL IMMUNOGLOBULINEMIA; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PLASMA CELL; PRIORITY JOURNAL; REMISSION; SIALYLATION; SIAT4A GENE; SIAT4B GENE; SIAT4CB GENE;

AGED; FEMALE; GLOMERULAR MESANGIUM; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOGLOBULIN A; PARAPROTEINEMIAS; PURPURA, SCHOENLEIN-HENOCH;

EID: 82255185561     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr131     Document Type: Article

References (20)

1. Leung JC, Tang SC, Lam MF et al. Charge-dependent binding of polymeric IgA1 to human mesangial cells in IgA nephropathy. Kidney Int 2001; 59: 277-285 (Pubitemid 32055236)
2. Suzuki H, Moldoveanu Z, Hall S et al. IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. J Clin Invest 2008; 118: 629-639 (Pubitemid 351206552)
3. Tomana M, Novak J, Julian BA et al. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest 1999; 104: 73-81 (Pubitemid 29534347)
4. Imai H, Nakamoto Y, Asakura K et al. Spontaneous glomerular IgA deposition in ddY mice: an animal model of IgA nephritis. Kidney Int 1985; 27: 756-761 (Pubitemid 15064635)
5. Launay P, Grossetete B, Arcos-Fajardo M et al. Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic mice. J Exp Med 2000; 191: 1999-2009 (Pubitemid 30390361)
6. Arrizabalaga P, Saurina A, Sole M et al. Henoch-Schonlein IgA glomerulonephritis complicating myeloma kidneys: case report. Ann Hematol 2003; 82: 526-528 (Pubitemid 37062755)
7. Birchmore D, Sweeney C, Choudhury D et al. IgA multiple myeloma presenting as Henoch-Schonlein purpura/polyarteritis nodosa overlap syndrome. Arthritis Rheum 1996; 39: 698-703
8. Preud'homme JL, Aucouturier P, Touchard G et al. Monoclonal immunoglobulin deposition disease (Randall type). Relationship with structural abnormalities of immunoglobulin chains. Kidney Int 1994; 46: 965-972 (Pubitemid 24319932)
9. Van Der Helm-Van Mil AH, Smith AC, Pouria S et al. Immunoglobulin A multiple myeloma presenting with Henoch-Schonlein purpura associated with reduced sialylation of IgA1. Br J Haematol 2003; 122: 915-917 (Pubitemid 37174611)
10. Zickerman AM, Allen AC, Talwar V et al. IgA myeloma presenting as Henoch-Schonlein purpura with nephritis. Am J Kidney Dis 2000; 36: E19
11. Dosa S, Cairns SA, Mallick NP et al. Relapsing Henoch-Schonlein syndrome with renal involvement in a patient with an IgA monoclonal gammopathy. A study of the results of immunosuppressant and cytotoxic therapy. Nephron 1980; 26: 145-148 (Pubitemid 10034667)
12. Terness P, Navolan D, Moroder L et al. A natural IgA-anti-F(ab') 2gamma autoantibody occurring in healthy individuals and kidney graft recipients recognizes an IgG1 hinge region epitope. J Immunol 1996; 157: 4251-4257 (Pubitemid 126449540)
13. Nishie T, Miyaishi O, Azuma H et al. Development of immunoglobulin A nephropathy-like disease in beta-1,4-galactosyltransferase-I-deficient mice. Am J Pathol 2007; 170: 447-456 (Pubitemid 47339382)
14. Amore A, Cirina P, Conti G et al. Glycosylation of circulating IgA in patients with IgA nephropathy modulates proliferation and apoptosis of mesangial cells. J Am Soc Nephrol 2001; 12: 1862-1871 (Pubitemid 32801361)
15. Chen N, Nusbaum P, Halbwachs-Mecarelli L et al. Light-chain composition of serum IgA1 and in vitro IgA1 production in IgA nephropathy. Nephrol Dial Transplant 1991; 6: 846-850
16. Monteiro RC, Halbwachs-Mecarelli L, Roque-Barreira MC et al. Charge and size of mesangial IgA in IgA nephropathy. Kidney Int 1985; 28: 666-671 (Pubitemid 16205803)
17. Lai KN, To WY, Li PK et al. Increased binding of polymeric lambda-IgA to cultured human mesangial cells in IgA nephropathy. Kidney Int 1996; 49: 839-845
18. Coppo R, Amore A, Roccatello D. Dietary antigens and primary immunoglobulin A nephropathy. J Am Soc Nephrol 1992; 2: S173-S180
19. Sategna-Guidetti C, Ferfoglia G, Bruno M et al. Do IgA antigliadin and IgA antiendomysium antibodies show there is latent coeliac disease in primary IgA nephropathy? Gut 1992; 33: 476-478
20. Monteiro RC, Chevailler A, Noel LH et al. Serum IgA preferentially binds to cationic polypeptides in IgA nephropathy. Clin Exp Immunol 1988; 73: 300-306